Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

tsxv:mrvl

POPULAR ARTICLES

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

LATEST ARTICLES

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Marvel Biosciences Corp.

Marvel Biosciences Corp.

Latest News

Corporate Presentation

Ignite Investment Summit Presentation

Golconda Gold Releases Q1 2026 Production Update and Announces Record Quarterly Production at the Galaxy Gold Mine

Brixton Metals Announces Option Grants

Trillion Energy Announces Light Oil Discovery

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Silver Hammer Mining

Silver Hammer Mining (HAMR:CC)

HAMR:CC

Angkor Resources

Angkor Resources (ANK:CC)

ANK:CC

Generation Uranium

Generation Uranium (GEN:CC)

GEN:CC

Prime Medicine

PRME

Cauldron Energy

CXU:AU

U92 Energy

U92 Energy (UTWO:CC)

UTWO:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES